| 51 | SOLVSolventum Corp |
$8.3B |
18.7% |
2025 |
| 52 | ICLRIcon PLC |
$8.3B |
2.8% |
2025 |
| 53 | ZBHZimmer Biomet Holdings, Inc. |
$8.2B |
8.6% |
2025 |
| 54 | ARDTArdent Health, Inc. |
$6.3B |
2.1% |
2025 |
| 55 | OGNOrganon & Co. |
$6.2B |
3.0% |
2025 |
| 56 | SNNSmith & Nephew PLC |
$6.2B |
10.1% |
2025 |
| 57 | EWEdwards Lifesciences Corp |
$6.1B |
17.7% |
2025 |
| 58 | STESTERIS plc |
$5.9B |
13.2% |
2026 |
| 59 | EHCEncompass Health Corp |
$5.9B |
9.5% |
2025 |
| 60 | AGLagilon health, inc. |
$5.9B |
-6.6% |
2025 |
| 61 | RMDResmed Inc |
$5.7B |
26.9% |
2026 |
| 62 | OPCHOption Care Health, Inc. |
$5.6B |
3.7% |
2025 |
| 63 | ONCBeOne Medicines Ltd. |
$5.3B |
5.4% |
2025 |
| 64 | PACSPACS Group, Inc. |
$5.3B |
3.6% |
2025 |
| 65 | INCYIncyte Corp |
$5.1B |
25.0% |
2025 |
| 66 | BLCOBausch & Lomb Corp |
$5.1B |
-7.1% |
2025 |
| 67 | ENSGEnsign Group, Inc |
$5.1B |
6.8% |
2025 |
| 68 | HLFHerbalife Ltd. |
$5B |
4.5% |
2025 |
| 69 | ELANElanco Animal Health Inc |
$4.7B |
-4.9% |
2025 |
| 70 | DXCMDexcom Inc |
$4.7B |
17.9% |
2025 |
| 71 | ILMNIllumina, Inc. |
$4.3B |
19.6% |
2025 |
| 72 | IDXXIdexx Laboratories Inc |
$4.3B |
24.6% |
2025 |
| 73 | JAZZJazz Pharmaceuticals plc |
$4.3B |
-8.3% |
2025 |
| 74 | PRGOPERRIGO Co plc |
$4.3B |
-33.5% |
2025 |
| 75 | COOCooper Companies, Inc. |
$4.1B |
9.2% |
2025 |
| 76 | ALGNAlign Technology Inc |
$4B |
10.2% |
2025 |
| 77 | CRLCharles River Laboratories International, Inc. |
$4B |
-3.6% |
2025 |
| 78 | ALHCAlignment Healthcare, Inc. |
$3.9B |
-0.0% |
2025 |
| 79 | RDYDR Reddys Laboratories Ltd |
$3.8B |
17.4% |
2025 |
| 80 | GMABGenmab A/S |
$3.7B |
25.9% |
2025 |
| 81 | ALNYAlnylam Pharmaceuticals, Inc. |
$3.7B |
8.4% |
2025 |
| 82 | XRAYDENTSPLY SIRONA Inc. |
$3.7B |
-16.3% |
2025 |
| 83 | ACHCAcadia Healthcare Company, Inc. |
$3.3B |
-33.3% |
2025 |
| 84 | SGRYSurgery Partners, Inc. |
$3.3B |
-2.4% |
2025 |
| 85 | AHCOAdaptHealth Corp. |
$3.2B |
-2.2% |
2025 |
| 86 | BMRNBiomarin Pharmaceutical Inc |
$3.2B |
10.8% |
2025 |
| 87 | BKDBrookdale Senior Living Inc. |
$3.2B |
-8.2% |
2025 |
| 88 | UTHRUNITED THERAPEUTICS Corp |
$3.2B |
41.9% |
2025 |
| 89 | MMEDMiniMed Group, Inc. |
$3.1B |
-10.7% |
2026 |
| 90 | WSTWest Pharmaceutical Services Inc |
$3.1B |
16.1% |
2025 |
| 91 | ULSUL Solutions Inc. |
$3.1B |
10.6% |
2025 |
| 92 | AMRXAmneal Pharmaceuticals, Inc. |
$3B |
2.4% |
2025 |
| 93 | GMEDGlobus Medical Inc |
$2.9B |
18.3% |
2025 |
| 94 | NBIXNeurocrine Biosciences Inc |
$2.9B |
16.7% |
2025 |
| 95 | ACHAccendra Health Inc |
$2.8B |
-39.8% |
2025 |
| 96 | QDELQuidelOrtho Corp |
$2.7B |
-41.5% |
2025 |
| 97 | FTREFortrea Holdings Inc. |
$2.7B |
-36.2% |
2025 |
| 98 | NVSTEnvista Holdings Corp |
$2.7B |
1.7% |
2025 |
| 99 | PODDInsulet Corp |
$2.7B |
9.1% |
2025 |
| 100 | MEDPMedpace Holdings, Inc. |
$2.5B |
17.8% |
2025 |